Seyed Ali Hosseini; Nasibeh Kazemi; Saeedeh Shadmehri; Shariat Jalili; Mozhgan Ahmadi
Abstract
Objectives: This study aimed to investigate the effect of resistance training in water and land with vitamin D on anti-Mullerian hormone in women with polycystic ovary syndrome (PCOS). Methods: Sixty women with PCOS (20 - 35 years old) referred to the Hafez Hospital in Shiraz in 2018 were selected and ...
Read More
Objectives: This study aimed to investigate the effect of resistance training in water and land with vitamin D on anti-Mullerian hormone in women with polycystic ovary syndrome (PCOS). Methods: Sixty women with PCOS (20 - 35 years old) referred to the Hafez Hospital in Shiraz in 2018 were selected and randomly divided into six groups of (1) control, (2) water training, (3) land training, (4) vitamin D, (5) water training with vitamin D, and (6) land training with vitamin D. Groups 2, 3, 5, and 6 performed resistance training in water and land for eight weeks, three sessions per week, while groups 4, 5 and 6 consumed vitamin D for eight weeks. For statistical analysis of data independent samples t-test, one-way ANOVA and Tukey’s post hoc tests were used (P ≤ 0.05). Results: Training in water and land have no significant effect on anti-Mullerian hormone (P ≥ 0.05); vitamin D, training in water with vitamin D, and training in land with vitamin D have significant effect on reduction of anti-Mullerian hormone (P = 0.001); training in water with vitamin D and training in land with vitamin D have more effect on reduction of anti-Mullerian hormone rather than vitamin D (P ≤ 0.05) and after training in water with vitamin D (P = 0.01) and training in land with vitamin D (P = 0.001) there is a significant relationship between anti-Mullerian hormone changes and weight. Conclusions: It appears that resistance training in water and land combined with vitamin D consumption may decrease the anti-Mullerian hormone by reduction in weight and as a result improve ovarian and reproductive function in women with PCOS.
Mahmood Soveid; Nasrin Asadi; Mahnoosh Sianati
Abstract
Background: There is biologic and clinical evidence that links vitamin D deficiency to pre-eclampsia. The Vitamin D receptor is present in the placenta, cardiovascular system, and lymphocytes. It has anti-inflammatory, immune regulatory, and anti-hypertensive properties and facilitates placental implantation. ...
Read More
Background: There is biologic and clinical evidence that links vitamin D deficiency to pre-eclampsia. The Vitamin D receptor is present in the placenta, cardiovascular system, and lymphocytes. It has anti-inflammatory, immune regulatory, and anti-hypertensive properties and facilitates placental implantation. Each of these processes is involved in the pathogenesis of pre-eclampsia.
Objectives: The main purpose of this study was to study the relationship between vitamin D deficiency and severe pre-eclampsia in a population residing in southern Iran that is generally known to have a high prevalence of vitamin deficiency. As a second objective, the prevalence of vitamin D deficiency in pregnant women was investigated.
Patients and Methods: We conducted a case-control study of 59 patients with severe preeclampsia and 217 controls, all of whom were from southern Iran. Cases and controls were matched for age, body mass index, and gestational age. The study was carried out in autumn and winter. Plasma 25-hydroxyvitamin D was measured using high performance liquid chromatography, and the results were compared between the two groups.
Results: Almost all controls and patients had 25-hydroxyvitamin D levels below normal, and 69% had levels below 10 ng/mL. The mean 25-hydroxyvitamin D levels in the patient and control groups were 8.4 (6.2) and 8.5 (6.9) ng/ml (P = 0.80), respectively. The level of 25-hydroxyvitamin D had no significant association with subjects’ body mass index or age.
Conclusions: Pregnant women in our region have a high prevalence of vitamin D deficiency, and in a population with severe vitamin D deficiency, there is no significant correlation between 25-hydroxyvitamin D levels and preeclampsia. Severe deficiency masks any possible association in a case-control study. Controlled trials with vitamin D supplementation are recommended for further studies.
Zamzam Paknahad; Azam Ahmadi Vasmehjani; Mohammad Reza Maracy
Abstract
Background: Epidemiological studies showed that vitamin D deficiency is associated with components of metabolic syndrome.
Objectives: The aim of the present study was to determine the association between serum 25 hydroxyvitamin D concentration and components of metabolic syndrome in Iranian adult women.
Patients ...
Read More
Background: Epidemiological studies showed that vitamin D deficiency is associated with components of metabolic syndrome.
Objectives: The aim of the present study was to determine the association between serum 25 hydroxyvitamin D concentration and components of metabolic syndrome in Iranian adult women.
Patients and Methods: This study was comprised of 156 women aged ≥ 30 years with at least three of the five criteria of metabolic syndromes. Serum 25-hydroxyvitamin D (25 (OH)D) levels and components of the metabolic syndrome were determined. Metabolic syndrome was defined according to NCEP/ATP III criteria. The subjects were classified into three groups according to their serum concentration of 25 (OH)D.
Results: Mean of serum concentration of 25-hydroxyvitamin D was 20.5 ± 10.8 ng/mL with %54.5, 23.1% and 22.4% of subjects were deficient, insufficient and sufficient in vitamin D, respectively. After adjustment for age, BMI, physical activity, and ANCOVA, fasting blood sugar concentration was shown to be inversely associated with serum 25 (OH)D (P = 0.004). On the other hand HDL-C showed significant correlation across different groups of vitamin D status (P = 0.014). Waist Circumference had favorable changes, without any statistically significant correlation. Also no significant association was observed between other components of metabolic syndrome and 25 (OH)D in different groups.
Conclusions: The components of metabolic syndrome are influenced by serum 25 (OH)D concentrations. The finding of this investigation revealed that FBS and HDL-C concentrations related to serum 25 (OH)D. Therefore, further longitudinal studies and randomized clinical trials are necessary to determine the possible role of vitamin D in prevention of diabetes and cardiovascular disease.
